Serum Institute of India launches low-cost HIB vaccine

Chennai, Aug 9 (UNI) Serum Institute of India Ltd, India's largest vaccine manufacturer today announced the launch of its indigenously manufactured low-cost Haemophilus influenza type B conjugate vaccine under the brand name of ''HibPRO'' in India.

HibPRO has been priced at MRP Rs 375 for a monodose vial, a company release here said.

Haemophilus influenza causes infections that are a major cause of morbidity and mortality in young children, spreading through droplets.

Children below five years of age faced the maximum risk of contracting the disease and it was rarely seen among children after five years.

Every year, globally around three to five lakh children die due to Haemophilus influenza type B disease.

HIB vaccines are safe and effective, the release added.

UNI